Back

Staring into the AβYSS: how many pills and for how long after myocardial infarction?

European Heart Journal

22 May 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes HYPERTENSION PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

John G F Cleland
John G F Cleland

Author

University of Glasgow Glasgow , United Kingdom of Great Britain & Northern Ireland

You may be interested in
thumbnail
Webinar
LDL-C reduction postACS: strike early and strike strong
15 November 2021
thumbnail
Congress Presentation
Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy.
27 August 2021
thumbnail
Congress Presentation
Polypill to improve adherence in cardiovascular secondary prevention: a real challenge in real practice
3 September 2019
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
17 November 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources